Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
7,887,542
-
Share change
-
-57,049
-
Total reported value
-
$712,684,853
-
Put/Call ratio
-
1120%
-
Price per share
-
$90.36
-
Number of holders
-
124
-
Value change
-
-$3,708,634
-
Number of buys
-
57
-
Number of sells
-
61
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q3 2025
As of 30 Sep 2025,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
124 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,887,542 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, CITIGROUP INC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Clal Insurance Enterprises Holdings Ltd, J.Safra Asset Management Corp, Avalon Trust Co, JPMORGAN CHASE & CO, and Miller Investment Management, LP.
This page lists
124
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.